ActiveNCT07051408

Predictors Of Cognitive Decline In Attenders Of Essex Memory Clinic From Digital Devices Using Classical Statistical Methods, Machine Learning And Disease Progression Modelling

Sponsor: University College, London

Trial Details

ConditionDementia, Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), Rapid Eye Movement Sleep Behavior Disorder, Healthy Control Patients of the Same Age
StatusActive
Participants135
Est. Completion18 Nov 2025
Last Updated14 May 2026

Primary Outcome

Mean proportion (%) of scheduled digital data capture visits fully completed for each digital technology (Fitbit Charge 4/5, Dreem 2/3 headband, Mezurio smartphone app, and Longevity smartphone app) at each timepoint; Mean proportion (%) of scheduled Mezurio data capture visits fully completed at each timepoint for individuals randomised to 14- and 28-day Mezurio schedules

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Patients who present to the Essex Memory Clinic and their relatives or carers 2. Capacity to provide written informed consent 3. Sufficient proficiency in English to understand study documents and use the digital devices 4. Own a compatible smartphone (Android 7.0 or higher / iOS 12.2 or higher). If participants own a smartphone which is not a compatible device (i.e. prior to Android 7.0 or iOS 12.2), a new handset will be provided to them, as long as they are willing to use this as their primary phone. 5. Ability to use a smartphone and EDoN digital devices, either alone, or with appropriate support (carer, partner, family member, etc). Support would involve reminding participants to complete study tasks and to charge / wear devices. 6. Able to connect to the internet using their smartphone at home. Note: In order to use the Dreem headband, participants will additionally require a home WiFi connection. However, participants without a WiFi connection will still be able to join the study and will not be asked to use the Dreem headband. 7. For people with a diagnosis of dementia, a carer, partner or family member willing to support their participation in the study by reminding patients to complete study tasks and to charge/wear their devices 8. For patients who do not have a record of neurocognitive and physical assessments outlined in section 4.5.3, they must be willing to undergo these additional assessments 9. For the blood donation sub study only: consented to participate in the main CODEC II study. 10. For the qualitative sub study only: able to use a phone or video-conferencing platform to participate in the interviews 11. Aged 40+ years Exclusion Criteria: 1. Patients with active major psychiatric disorder which requires regular reviews by secondary care, for example schizophrenia, schizoaffective disorder or bipolar affective disorder 2. Patients under end-of-life care 3. Previous sensitivity or allergic skin reaction to latex, rubber or plastics 4. Do not have a personal smartphone with internet access 5. Participating in a clinical trial of an investigational medicinal product 6. Not meeting all inclusion criteria

Trial Sites

Countries

United Kingdom
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service